Identification of Functional Determinants of Response and Resistance to CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy of Chronic Lymphocytic Leukemia

被引：0
|
作者：
Fraietta, Joseph A.
Lacey, Simon F.
Orlando, Elena
Pruteanu, Julian
Gohil, Mercy
Wang, Yan
Boesteanu, Alina
OConnor, Roddy
Ambrose, David E.
Hwang, Wei-Ting
Wilcox, Nicholas
Bedoya, Felipe
Dorfmeier, Corin
Chen, Fang
Parakandi, Harit
Gupta, Minnal
Pequignot, Edward
Johnson, F. Brad
Kulikovskaya, Irina
Liu, Li
Lundh, Stefan M.
Xu, Jun
Davis, Megan M.
Young, Regina M.
Levine, Bruce L.
Siegel, Don L.
Huang, Alexander
Wherry, E. John
Zhou, Jing
Paczkowski, Patrick
Mackay, Sean
Brogdon, Jennifer
Bitter, Hans
Porter, David L.
June, Carl H.
Melenhorst, J. Joseph
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3181
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Efficacy of CD19 Directed Therapies in Large B-Cell Lymphoma (LBCL) Relapsing after Chimeric Antigen Receptor (CAR) T-Cell Therapy
    Iqbal, Madiha
    Khurana, Arushi
    Chavez, Julio
    Rosenthal, Allison C.
    Li, Zhuo
    Craver, Emily
    Aditi, Saha
    Epperla, Narendranath
    Annunzio, Kaitlin
    Awan, Farrukh T.
    Isufi, Iris
    Dholaria, Bhagirathbhai
    Bhaskar, Shakthi
    Maakaron, Joseph
    Sumransub, Nuttavut
    Fijalka, Andrew
    Sandoval-Sus, Jose
    Ivanov, Stanislav
    Lin, Yi
    Kharfan-Dabaja, Mohamed A.
    BLOOD, 2022, 140 : 10396 - 10398
  • [42] Infectious complications, immune reconstitution, and infection prophylaxis after CD19 chimeric antigen receptor T-cell therapy
    Wudhikarn, Kitsada
    Perales, Miguel-Angel
    BONE MARROW TRANSPLANTATION, 2022, 57 (10) : 1477 - 1488
  • [43] Infectious complications, immune reconstitution, and infection prophylaxis after CD19 chimeric antigen receptor T-cell therapy
    Kitsada Wudhikarn
    Miguel-Angel Perales
    Bone Marrow Transplantation, 2022, 57 : 1477 - 1488
  • [44] Infectious Complications Following CD19 Chimeric Antigen Receptor T-cell Therapy for Children, Adolescents, and Young Adults
    Vora, Surabhi B.
    Waghmare, Alpana
    Englund, Janet A.
    Qu, Pingping
    Gardner, Rebecca A.
    Hill, Joshua A.
    OPEN FORUM INFECTIOUS DISEASES, 2020, 7 (05):
  • [45] Improving therapy of chronic lymphocytic leukemia with chimeric antigen receptor T cells
    Fraietta, Joseph A.
    Schwab, Robert D.
    Maus, Marcela V.
    SEMINARS IN ONCOLOGY, 2016, 43 (02) : 291 - 299
  • [46] Exploring BAFF-R as a Novel Target for Chimeric Antigen Receptor T-Cell Therapy in Chronic Lymphocytic Leukemia
    Luo, Yan
    Qie, Yaqing
    Gadd, Martha
    Li, Shuhua
    Hundal, Tanya
    Murthy, Hemant
    Dronca, Roxana
    Kharfan-Dabaja, Mohamed A.
    Qin, Hong
    MOLECULAR THERAPY, 2024, 32 (04) : 829 - 829
  • [47] Tisagenlecleucel, an approved anti-CD19 chimeric antigen receptor T-cell therapy for the treatment of leukemia
    Liu, Y.
    Chen, X.
    Han, W.
    Zhang, Y.
    DRUGS OF TODAY, 2017, 53 (11) : 597 - 608
  • [48] Chimeric Antigen Receptor (CAR) T-cell Therapy in Neurological Disorders
    Habib, Ali
    Ciurea, Stefan
    Kamboh, Hafsa
    Miljkovic, Milos
    Mozaffar, Tahseen
    NEUROLOGY, 2024, 103 (07) : S119 - S120
  • [49] Point of care CD19 chimeric antigen receptor (CAR) T-cells for relapsed/ refractory acute myeloid leukemia (AML) with aberrant CD19 antigen expression
    Danylesko, Ivetta
    Shem-Tov, Noga
    Yerushalmi, Ronit
    Jacoby, Elad
    Toren, Amos
    Shouval, Roni
    Itzhaki, Orit
    Avigdor, Abraham
    Shimoni, Avichai
    Nagler, Arnon
    CURRENT RESEARCH IN TRANSLATIONAL MEDICINE, 2024, 72 (04)
  • [50] Identification of genomic signatures in bone marrow associated with clinical response of CD19 CAR T-cell therapy
    Lipei Shao
    Avinash Iyer
    Yingdong Zhao
    Rob Somerville
    Sandhya Panch
    Alejandra Pelayo
    David F. Stroncek
    Ping Jin
    Scientific Reports, 12
12345